Singapore markets closed

Innate Pharma S.A. (IPHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8800+0.5100 (+21.52%)
At close: 04:00PM EDT
2.8800 0.00 (0.00%)
After hours: 04:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.3700
Open2.3780
Bid2.2500 x 1000
Ask2.7000 x 900
Day's range2.3780 - 2.9000
52-week range1.8100 - 3.5700
Volume57,653
Avg. volume10,522
Market cap232.825M
Beta (5Y monthly)0.66
PE ratio (TTM)N/A
EPS (TTM)-0.8600
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.40
  • Insider Monkey

    Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript

    Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: At this time, I would like to welcome everyone to the Innate Pharma Full Year 2023 Financial […]

  • Business Wire

    Innate Pharma Reports Full Year 2023 Financial Results and Business Update

    MARSEILLE, France, March 21, 2024--Innate Pharma reports Full Year 2023 financial results and business update

  • Business Wire

    Innate Pharma Announces Its Participation to Upcoming Investor Conference

    MARSEILLE, France, March 19, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below. Participants will be Sonia Quaratino, Executive Vice President, Chief Medical Officer, Yannis Morel, Executive Vice President, Chief Operating Officer and Arvind Sood, Executive Vice President, President of US Operations.